Stephanie Santos

London, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Segmental Copy Number Variant Detection Using an Amplicon-Based Next-Generation Sequencing Panel for Integrated Glioma Classification.

Segmental Copy Number Variant Detection Using an Amplicon-Based Next-Generation Sequencing Panel for Integrated Glioma Classification.

Journal: The Journal of molecular diagnostics : JMD

Published: October 22, 2025

Segmental Copy Number Variant Detection Using an Amplicon-based NGS Panel for Integrated Glioma Classification.

Segmental Copy Number Variant Detection Using an Amplicon-based NGS Panel for Integrated Glioma Classification.

Journal: The Journal of molecular diagnostics : JMD

Published: October 22, 2025

Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).

Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).

Journal: The Journal of molecular diagnostics : JMD

Published: May 28, 2025

Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).

Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).

Journal: The Journal of molecular diagnostics : JMD

Published: May 28, 2025

Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratory.

Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratory.

Journal: Frontiers in oncology

Published: April 18, 2023

Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.

Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.

Journal: Molecular diagnosis & therapy

Published: March 01, 2022

Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?

Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?

Journal: International journal of laboratory hematology

Published: August 06, 2021

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood.

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood.

Journal: JTO clinical and research reports

Published: May 11, 2021

Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.

Clinical value of next-generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome.

Journal: British journal of haematology

Published: March 12, 2020

Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.

Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.

Journal: European journal of haematology

Published: March 18, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026